UnitedHealth Group Incorporated (UNH) Stock
NYSEUNH has an Alpha Score of 46 out of 100 (weak), computed on Oct 28, 2026 from 3 of 4 sub-scores. 64 members of Congress disclosed 213 trades in UNH since 2014: 110 purchases and 103 sales, most recently Maria Elvira Salazar (partial sale, Sep 24, 2026). 7 of the hedge funds AlphaScala tracks reported UNH in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Marshall Wace's at $761.87M. Company insiders reported 0 open-market buys and 2 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 23.5 and its net margin 3.5% (key statistics as of Oct 22, 2026).
What is UNH's Alpha Score?
How it works →Alpha Score of 46 reflects weak overall profile with strong momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 28, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded UnitedHealth Group Incorporated (UNH)?
Most recent: Maria Elvira Salazar (partial sale, Sep 24, 2026); records start Apr 28, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Maria Elvira Salazar R-FL · House | 2026-09-24 | partial sale | $1k – $15k |
| Kevin Hern R-OK · House | 2026-09-23 | sale | $15k – $50k |
| Kevin Hern R-OK · House | 2026-09-10 | sale | $15k – $50k |
| Rich McCormick R-GA · House | 2026-07-30 | sale | $1k – $15k |
| Dan Newhouse R-WA · House | 2026-07-10 | sale | $1k – $15k |
| Rich McCormick R-GA · House | 2026-06-12 | partial sale | $1k – $15k |
| Maria Elvira Salazar R-FL · House | 2026-06-04 | sale | $1k – $15k |
| John Boozman R-AR · Senate | 2026-06-04 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded UNH, with filing lags →Which hedge funds own UNH?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 1.83M | $761.87M | +30% |
| Millennium Management Israel Englander | 1.62M | $672.35M | +19% |
| Citadel Ken Griffin | 1.06M | $442.29M | -31% |
| Point72 Steve Cohen | 831K | $345.33M | +98% |
| D.E. Shaw David Shaw | 494K | $205.20M | -58% |
| Renaissance Technologies Jim Simons (founder) | 367K | $152.54M | -68% |
| Tiger Global Chase Coleman | 297K | $123.63M | -15% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are UnitedHealth Group Incorporated insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 26 | Conway Patrick Hugh | Chief Executive Officer, Optum | SELL | 1.2K | $456K |
| Aug 5, 26 | Conway Patrick Hugh | Chief Executive Officer, Optum | SELL | 500 | $205K |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are UNH's key statistics?
Key statistics as of Oct 22, 2026
How does UNH's valuation compare with the Healthcare sector?
| Metric | UNH | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 23.5 | 27.1 | 97 |
| Net margin | 3.53% | 5.48% | 139 |
| Return on equity | 16.10% | 6.84% | 158 |
| Dividend yield (payers) | 1.37% | 1.62% | 50 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
What did UnitedHealth Group Incorporated's latest SEC filings say?
Latest 4UnitedHealth Group Announces Participation in Upcoming Barclays Global Healthcare Conference Presentation
UnitedHealth Group Incorporated filed an 8-K on March 9, 2026, to provide notice of its participation in the Barclays 28th Annual Global Healthcare Conference. The company stated that senior leadership will engage in an interview format to discuss corporate strategy, current market positions, recent financial results, and expectations for its end markets. The presentation is scheduled for Tuesday, March 10, 2026, at 11:30 a.m. Eastern Time. The company will provide a live audio webcast of the session through the Investor Relations section of its corporate website. In accordance with Regulation FD, the company noted that the information provided in this filing is for disclosure purposes and is not deemed filed under the Securities Exchange Act of 1934.
- ›UnitedHealth Group leadership to present at Barclays 28th Annual Global Healthcare Conference.
- ›Presentation scheduled for March 10, 2026, at 11:30 a.m. Eastern Time.
- ›Management to discuss company strategy, market positions, and recent financial results.
- ›Discussion will include outlook and expectations for company end markets.
- ›Live audio webcast to be hosted on the company investor relations website.
UnitedHealth Group Appoints Dennis Stankiewicz as Chief Accounting Officer Effective March 2026
UnitedHealth Group Incorporated filed an 8-K report on March 2, 2026, to announce leadership changes within its executive accounting and finance departments. Effective March 2, 2026, the Board of Directors appointed Dennis Stankiewicz as the company's Chief Accounting Officer. Stankiewicz, 48, has been with UnitedHealth Group since 2016 and will retain his current responsibilities as Corporate Controller. Prior to his tenure at the company, Stankiewicz served as a partner at Deloitte & Touche, LLP and possesses over 24 years of professional experience. In connection with his appointment, the Compensation and Human Resources Committee established a new compensation package for Stankiewicz. This includes an annual base salary of $550,000 and participation in the company's incentive compensation plans. His target annual cash bonus is set at 85% of his base salary, supplemented by annual and long-term stock-based awards commensurate with his role. The agreement also provides for severance benefits equal to one times his base salary in the event of termination without cause, subject to non-compete provisions. Tom Roos, who held the position of Chief Accounting Officer since August 2015, is transitioning to a new role within the organization. Effective March 2, 2026, Roos will serve as the Chief Financial Officer of Optum Insight. The filing confirms that Stankiewicz has no reportable conflicts of interest or transactions with the company under Item 404(a) of Regulation S-K.
- ›Dennis Stankiewicz appointed as Chief Accounting Officer effective March 2, 2026.
- ›Stankiewicz retains his existing role as Corporate Controller.
- ›Tom Roos transitions from Chief Accounting Officer to CFO of Optum Insight.
- ›Stankiewicz granted $550,000 base salary and 85% annual cash bonus target.
- ›Severance package established for Stankiewicz equal to one times base salary.
UnitedHealth Group 10-K Filing Details Financial Position and Operational Restructuring for 2025
UnitedHealth Group Incorporated filed its 10-K for the fiscal year ending December 31, 2025. The filing outlines the company's consolidated financial position, including detailed breakdowns of its primary business segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The report highlights ongoing financial activities, including the management of long-term debt obligations, various notes due between 2026 and 2049, and the valuation of intangible assets. Management disclosed specific charges related to restructuring and other actions, including real estate rationalization and workplace reductions, as well as contractual reassessments. The company also recorded reserves for anticipated future losses on certain contracts and recognized net valuation losses on equity securities. The filing provides comprehensive data on fair value measurements for debt securities and long-term debt, categorized by input levels. The company continues to manage pharmaceutical manufacturer rebates receivable and maintains various insurance product lines. The document serves as the formal annual record of the company's assets, liabilities, and equity adjustments, reflecting the operational shifts and financial strategies employed throughout the 2025 fiscal year.
- ›Recognized charges for real estate rationalization and workplace reductions.
- ›Established reserves for anticipated future losses on specific contracts.
- ›Recorded net valuation losses on equity securities.
- ›Updated fair value measurements for long-term debt and debt securities.
- ›Continued management of pharmaceutical manufacturer rebates receivable.
UnitedHealth Group Amends Stock Option Terms for Director Stephen Hemsley
On February 23, 2026, the Compensation and Human Resources Committee of the UnitedHealth Group Incorporated Board of Directors approved an amendment to a stock option grant previously awarded to Stephen Hemsley on May 14, 2025. The primary change to the compensation agreement involves the addition of a mandatory share holding requirement. Under the revised terms, Mr. Hemsley is required to hold any net shares acquired through the exercise of the stock option for a period of two years following the initial three-year cliff vesting period. Consequently, these shares must be held until May 14, 2030. The amendment includes specific exceptions to this holding requirement only in the event of the director's death or disability. All other terms and conditions of the original stock option grant remain in effect as previously disclosed in the company's 8-K filing dated May 14, 2025.
- ›Amended stock option agreement for Stephen Hemsley.
- ›Added a two-year post-vesting share holding requirement.
- ›Mandated that net shares must be held until May 14, 2030.
- ›Established exceptions to the holding period for death or disability.
UNH price chart
Powered by TradingViewWhat does UnitedHealth Group Incorporated do?
UnitedHealth Group Incorporated is a leading diversified health care company providing coverage, software, and data consultancy services. It operates through key segments including UnitedHealthcare for health insurance, OptumHealth for care delivery, OptumInsight for data analytics and technology, and OptumRx for pharmacy services. Founded in 1977 and headquartered in Eden Prairie, Minnesota, the company employs approximately 400,000 people and serves millions of individuals, employers, and government programs across the United States. UnitedHealth Group Incorporated plays a pivotal role in the healthcare sector by integrating insurance with advanced health services, technology solutions, and pharmacy benefits management to enhance care quality, affordability, and accessibility. Its extensive operations influence major areas such as Medicare Advantage plans, health data analytics, and provider partnerships, contributing significantly to the U.S. health system's efficiency and innovation.